Graypoint LLC’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.08M | Buy |
44,467
+2,573
| +6% | +$62.4K | 0.06% | 200 |
|
|
2025
Q1 | $1.06M | Buy |
41,894
+1,366
| +3% | +$34.6K | 0.07% | 194 |
|
|
2024
Q4 | $1.08M | Buy |
40,528
+3,911
| +11% | +$104K | 0.07% | 188 |
|
|
2024
Q3 | $1.06M | Buy |
36,617
+3,852
| +12% | +$111K | 0.07% | 183 |
|
|
2024
Q2 | $917K | Buy |
32,765
+566
| +2% | +$15.8K | 0.06% | 189 |
|
|
2024
Q1 | $894K | Sell |
32,199
-1,361
| -4% | -$37.8K | 0.06% | 189 |
|
|
2023
Q4 | $966K | Sell |
33,560
-15,765
| -32% | -$454K | 0.08% | 168 |
|
|
2023
Q3 | $1.64M | Sell |
49,325
-1,090
| -2% | -$36.2K | 0.15% | 116 |
|
|
2023
Q2 | $1.85M | Sell |
50,415
-3,390
| -6% | -$124K | 0.18% | 94 |
|
|
2023
Q1 | $2.2M | Sell |
53,805
-7,574
| -12% | -$309K | 0.24% | 82 |
|
|
2022
Q4 | $3.15M | Sell |
61,379
-3,482
| -5% | -$178K | 0.38% | 68 |
|
|
2022
Q3 | $2.84M | Buy |
64,861
+5,026
| +8% | +$220K | 0.37% | 70 |
|
|
2022
Q2 | $3.14M | Sell |
59,835
-1,626
| -3% | -$85.2K | 0.4% | 65 |
|
|
2022
Q1 | $3.18M | Buy |
61,461
+7,832
| +15% | +$405K | 0.31% | 70 |
|
|
2021
Q4 | $3.17M | Buy |
53,629
+3,680
| +7% | +$217K | 0.33% | 71 |
|
|
2021
Q3 | $2.15M | Buy |
49,949
+1,348
| +3% | +$58K | 0.26% | 76 |
|
|
2021
Q2 | $1.9M | Sell |
48,601
-875
| -2% | -$34.3K | 0.25% | 74 |
|
|
2021
Q1 | $1.79M | Sell |
49,476
-5,347
| -10% | -$194K | 0.27% | 77 |
|
|
2020
Q4 | $2.02M | Sell |
54,823
-8,416
| -13% | -$310K | 0.35% | 65 |
|
|
2020
Q3 | $2.2M | Sell |
63,239
-6,594
| -9% | -$230K | 0.43% | 63 |
|
|
2020
Q2 | $2.17M | Buy |
69,833
+1,520
| +2% | +$47.2K | 0.49% | 57 |
|
|
2020
Q1 | $2.12M | Buy |
+68,313
| New | +$2.12M | 0.59% | 50 |
|